singapore
Promising Results For Takeda’s Dengue Vaccine
Takeda's dengue vaccine has proven to be safe and able to produce an antibody response against all four serotypes of dengue in an interim analysis of their ongoing Phase 2 trial.
A*STAR & Chugai’s Anti-Dengue Antibody Project Receives GHIT Funding
The Global Health Innovative Technology Fund has awarded a US$5.3 million grant to help develop an antibody that can neutralize all four dengue serotypes.
Tessa Therapeutics Completes Acquisition of Euchloe Bio
Tessa Therapeutics has fully acquired Euchloe Bio, a biotech company focused on developing and commercializing therapeutic antibodies.
Asians With Type 2 Diabetes At Greater Risk Of Cancer
Researchers have found that type 2 diabetes is linked with a 26 percent increase in the risk of death from cancer in Asians.
NTU Singapore Collaborates With Chinese & Japanese Institutions
NTU Singapore partners with University of Chinese Academy of Sciences for artificial intelligence research and Japan's RIKEN for human biology studies.
A Biologist’s Dream Budget
In a perfect world where research funding isn’t so hard to come by, a biologist would definitely get all of these—clone and all.
Yellow Cabs Get Into Fewer Accidents Than Blue Ones
Painting all taxis in Singapore yellow could help save US$1.4 million a year, scientists estimate.
Putting The ‘Public’ In Public Policy
To better engage the public, policy-makers need new and better ways of dealing with unintended consequences, says SMU Professor David Chan, speaking at the SMU Behavioural Sciences Institute's recent conference on 'Unintended Consequences in Singapore'.
Thriving In An Uncertain World
A culture of innovation is needed for Singapore to shine, says SMU President Professor Arnoud De Meyer, speaking at the SMU Behavioural Sciences Institute's recent conference on 'Unintended Consequences in Singapore'.
